Pasar al contenido principal

PHYSIOLOGICAL AND ECOLOGICAL IMPACT OF PRE- AND PROBIOTIC INTERVENTIONS IN RELATION TO FOOD ALLERGY IN EARLY-LIFE.

PCI2021-122059-2A

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Afrontar las Prioridades de Nuestro Entorno
Subprograma Subprograma Estatal de Internacionalización
Convocatoria Proyectos Programación Conjunta Internacional
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of vertical and horizontal microbial transmission of antimicrobial resistance genes in early life: insights from maternal-infant dyads

  • Bernabeu, Manuel
  • Cabello Yeves, Elena
  • Flores, Eduard
  • Samarra, Anna
  • Kimberley Summers, Joanna
  • Marina, Alberto
  • Collado, María Carmen
Early life represents a critical window for metabolic, cognitive and immune system development, which is influenced by the maternal microbiome as well as the infant gut microbiome. Antibiotic exposure, mode of delivery and breastfeeding practices modulate the gut microbiome and the reservoir of antibiotic resistance genes (ARGs). Vertical and horizontal microbial gene transfer during early life and the mechanisms behind these transfers are being uncovered. In this review, we aim to provide an overview of the current knowledge on the transfer of antibiotic resistance in the mother-infant dyad through vertical and horizontal transmission and to highlight the main gaps and challenges in this area., This work has been supported by PROMETEO GVA (NEOHEALTH ref. 2020/012). The authors acknowledge the comments and suggestions of Dr. Raul Cabrera-Rubio. who thanks the Generalitat-Valenciana for the grant of the Plan GenT project (CDEIGENT 2020). M.B. thanks to the post-PhD grant 'Juan de la Cierva' (ref. JDC2022-050269-I) supported by the Spanish Ministry of Science, Innovation and Universities/State Investigation Agency (MCIU/AEI) and the European Union 'NextGenerationEU'/PRTR. E.C-Y received a FPI predoctoral fellowship from the Spanish Ministry of Science and Innovation with identifier PRE2020-092531. E.F.V thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). A.S. acknowledges Generalitat-Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant. M.C.C. acknowledges the support by the European Research Council Starting grant (MAMI grant ref. 639226), Horizon Europe Program (INITIALISE ref. 101094099), Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00), by the Joint Action 'European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)' — FOOD-HYPERSENS call (ECOBIOTIC) and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Government (Ministry of Science, Innovation and Universities) and also by Biostime Institute Nutrition & Care (BINC) grant. IATA-CSIC authors also acknowledge the Spanish government Ministry of Science and Innovation/State Investigation Agency (MCIN/AEI) to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). A.M. acknowledges the support by grants PID2019-108541GB-I00 and PID2022-137201NB-I00 from Spanish Government (Ministry of Science and Innovation). M.C.C. and A.M. are part of the CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of maternal diet on microbiota and health during pregnancy: a systematic review and correlational meta-analysis

  • Flores Ventura, Eduard
  • Selma-Royo, Marta
  • Turjeman, Sondra
  • González, Sonia
  • Koren, Omry
  • Collado, María Carmen
Pregnancy complications like gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy, and obesity are rising. Emerging evidence suggests dietary strategies targeting maternal microbiota, such as increased fiber or polyphenols, may help manage these conditions., EFV thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within 7the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). MSR thanks the support received from the MSCA-IF postdoctoral grant (DIAMMOND-101210012). MCC thanks the support by the Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00); the Joint Action European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)”-FOOD-HYPERSENS call (ECOBIOTIC); and national funding from the Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A) from the Spanish government (Ministry of Science, Innovation, and Universities), LaMaratò-TV3 project (DIM-2-ELI, ref. 2018–27/31) and Biostime Institute for Nutrition & Care—BINC Foundation and also, the awards from Jesus Serra Foundation and Reckitt Nutrition. IATA-CSIC authors also acknowledge the Spanish government MCIN/AEI to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). The work of OK and ST was supported by grant 1001576036 from the Ministry of Innovation Science and Technology and grants Cure2023007 and SPCL2023007 from The Russell Berrie Galilee Diabetes SPHERE., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An Old Story Back: Human Milk Antibodies' Protective Roles Against Allergy Development

  • Jackson, Courtney M.
  • Collado, María Carmen
  • Dallas, David C.
  • Insel, Richard A.
  • Macpherson, Andrew J.
  • Palmer, Debra J.
  • Seppo, Antti E.
  • Verhasselt, Valerie
  • Järvinen, Kirsi M.
Human milk is a rich source of immunomodulatory factors that influence the development of the infant immune system, including susceptibility to allergic diseases. Among these components, milk antibodies have been extensively studied for their role in protecting against infections; however, their potential contribution to allergy prevention may be equally important. The mechanisms of protection include allergen exclusion, enhanced and targeted antigen presentation, immune modulation via shaping of the infant gut microbiome, and direct regulation of gut immune responses. This review summarizes current evidence on the secretion of human milk antibodies, highlights what is known and what remains unclear about their role in allergy prevention and outlines the need for further research to develop antibody-based strategies for early allergy prevention., his work was supported by H2020-ERC Starting Grant (MAMI, ref. 639226), Horizon Europe Program (INITIALISE, ref. 101094099), the Joint Action ‘European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)’—FOOD-HYPERSENS call (ECOBIOTIC), Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), NIH R01HD109193, R01HD097367 and R01HD106140, Family Larsson Rosenquist Foundation, Stan Perron Charitable Foundation Fellowship, National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers U19AI175113 and U01AI173032., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human Milk Bioactive Compounds and Allergic- and Infectious-Related Infant Outcomes: A Systematic Review

  • Flores Ventura, Eduard
  • Guseva, Daria
  • Hübert, Vanessa
  • Samarra, Anna
  • Ensenauer, Regina
  • Collado, María Carmen
The impact of Human Milk (HM) bioactive compounds on infant health is crucial yet complex. Current research highlights their role in immune system development and disease prevention. This review aims to synthesize existing literature on the role of HM's bioactive compounds in the onset of diagnosed allergies, immunological diseases, and responses to infectious diseases by infants and children up to 18 years. The systematic review adhered to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). A comprehensive search strategy was employed across PubMed, Web of Science, SCOPUS, Scientific Electronic Library Online (SciELO), Cochrane Library, Latin American and Caribbean Health Sciences Literature (LILACS), and LIVIVO. Quality assessment utilized Joanna Briggs Institute checklists for various study designs. Protocol: CRD42023432030. The systematic review encompassed 34 studies, published from 1983 to 2024, representing a total of 9,298 mother-infant dyads. Included studies reported that allergic-related conditions, particularly food allergy, sensitization, and atopic dermatitis, were inversely associated with HM linolenic and linoleic acid. In a meta-analysis of three studies, infants with atopic dermatitis showed lower total omega-3 levels (SMD = -0.46, 95% CI: -1.82 to -0.90, I2 = 91%, p < 0.01), with reduced EPA and DGLA, suggesting, but not confirming, a potential protective role of omega-3 and involvement of inflammatory pathways. Furthermore, results on infectious-related conditions, primarily diarrhoea and Group B Streptococcus (GBS) infections, suggested inverse associations with 2'-fucosyllactose (2´-FL), lacto-N-difucohexaose I (LDFH-I), and immunoglobulins (Anti-GBS secretory immunoglobulin A (SIgA), anti-lipopolysaccharide IgA (Anti-LPS IgA), anti-cholera toxin IgA, respectively). Results of studies on upper and lower respiratory tract infections, otitis media, and dental caries suggested inverse associations with galectins and galectin-3, lacto-N-tetraose (LNT), 2´-FL, and Haemophilus influenzae. Data suggest that HM bioactive compounds, such as polyunsaturated fatty acids (PUFAs), HMOs, and a number of specific immunoglobulin A (IgA) antibodies may influence allergic and infectious outcomes in infants. In pooled analyses of omega-3 levels, HM fed to infants with atopic dermatitis showed reduced EPA and DGLA. However, these pooled estimates are severely limited by high statistical heterogeneity (I2 = 91%) and should be interpreted as exploratory findings. Despite of the limited overall evidence due to heterogeneity, low replication, and methodological variability, this review offers a broad synthesis of current findings and highlights key knowledge gaps, providing a foundation for future research focused on elucidating the immunological roles of understudied components, such as antimicrobial peptides, through multi-omics and longitudinal approaches., E.F.V. was supported by a predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for doctoral training within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). E.F.V. and M.C.C. also acknowledge support from the Spanish Ministry of Science and Innovation (MAMI-Plus project, ref. PID2022-139475OB-I00), as well as from the Joint Action, “European Joint Programming Initiative: A Healthy Diet for a Healthy Life” (JPI-HDHL) FOOD-HYPERSENS call (ECOBIOTIC project, ref. MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR), and national funding from the Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A) of the Spanish Ministry of Science, Innovation and Universities. The IATA-CSIC team acknowledges the award from the Spanish Government (MCIN/AEI) to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as a Centre of Excellence Severo Ochoa (CEX2021-001189-S, MCIN/AEI/10.13039/501100011033), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbial metabolites at the front line: Orchestrating gastrointestinal and systemic barrier immunity across the lifespan

  • Koren, Omry
  • Collado, María Carmen
  • Chassaing, Benoit
  • Silverman, Michael A
Microbiota-derived metabolites are central mediators between commensal microbes and host immune system at mucosal barrier surfaces. Insights from mouse models have revealed precise molecular mechanisms by which numerous metabolites, including short-chain fatty acids, tryptophan catabolites and bile acid derivatives, regulate epithelial integrity, innate immune tone, and adaptive immunity and tolerance. Parallel studies in humans increasingly confirm these pathways and link metabolite dysregulation to diseases, such as inflammatory bowel disease, asthma, and atopic dermatitis. This review synthesizes current understanding of how microbial metabolites orchestrate gastrointestinal barrier immunity, while also integrating emerging insights into the gut-lung and gut-skin axes. Crucially, we examine these interactions through a developmental lens, highlighting how metabolite exposure during critical early-life "windows of opportunity" shapes long-term immune trajectories. We integrate evidence from experimental models and human data to highlight conserved mechanisms, species-specific divergences, and the therapeutic potential of targeting these metabolic pathways as strategies to promote barrier health and durable immune homeostasis., L.K. is funded by P01 AI179570, R01AI171980, R01AI191417, R01DK129552, and the Cystic Fibrosis Foundation. B.C. is supported by a Starting Grant (grant agreement invaders no. ERC-2018-StG-804135) and a Consolidator Grant (grant agreement InterBiome no. ERC-2024-CoG-101170920) from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program, ANR grants EMULBIONT (ANR-21-CE15-0042-01) and DREAM (ANR-20-PAMR-0002), grant from the AFA Crohn RCH France and from the French government through the France 2030 investment plan managed by the National Research Agency (ANR), as part of the ANR-24-PESA-0008 and ANR-23-IAHU-0012. O.K. is supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement ERC-2020-COG no. 101001355), Israel Science Foundation (1527/21) and the Israeli Ministry of Innovation, Science & Technology. M.C.C. acknowledge support from H2020-ERC Starting Grant (MAMI, ref. 639226), Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI plus, ref. PID2022-139475OB-I00), EU Horizon Europe Programme grant (INITIALISE ref. 101094099), Excellence Research Group-Generalitat Valenciana (GVA) Prometeo Program (NeoHealth ref. PROMETEO2020/12 & Microglocal ref. CIPROM2023/030), as well as from the Joint Action, “European Joint Programming Initiative: A Healthy Diet for a Healthy Life” (JPI-HDHL) FOOD-HYPERSENS call (ECOBIOTIC project, ref. MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR)-national funding from the Programación Conjunta Internacional (PCI)-MCIN (ref. PCI2021-122059-2A). M.C.C. also acknowledges the award from the Spanish Government (MCIN/AEI) to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as a Centre of Excellence Severo Ochoa (CEX2021-001189-S, MCIN/AEI/10.13039/501100011033)., and the support from the Scientific Network Conexion Resistencia Antimicrobianos, Conexion Genoma and Conexion Microbioma funded by the Consejo Superior de Investigaciones Científicas (CSIC), Spain. M.A.S. is funded by R01DK133453, 1R01AI187202, and U19AI174998, Breakthrough T1D (CDA-2020-946-S-B) and Leona M. and Harry B. Helmsley Charitable Trust (2203–05843)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiota Signatures in Early Life and Their Association With Food Allergy: A Systematic Review

  • Flores Ventura, Eduard
  • Corriger, Jeremy
  • Omer, Hélène
  • Bodinier, Marie
  • Haller, Dirk
  • Hertz, Tomer
  • Larsen, Martin
  • Collado, María Carmen
Food allergy (FA) is increasing worldwide, and early life may be a critical window for immune training. We systematically reviewed observational human studies linking early-life microbiota (infant, maternal, environmental, or extraintestinal) profiled using culture-based and/or culture-independent methods (including sequencing-based approaches) to subsequent FA or food sensitization outcomes in infants, children, and adolescents up to 18 years of age. PubMed, Web of Science Core Collection, Embase, Scopus, and LILACS were searched from database inception to March 2026. Inclusion required microbiota sampling during pregnancy or childhood and clinically ascertained FA/sensitization; non-human studies and studies without sequencing or clinical outcomes were excluded. Risk of bias was assessed using QUIPS. Owing to heterogeneity, we performed narrative synthesis. Forty studies were included (n = 6530 participants; 2077 cases). Across cohorts, cases were associated with lower diversity, early beta-divergence (1-6 months), neonatal enrichment of Proteobacteria (Pseudomonadota)/Enterobacteriaceae and selected taxa (Clostridium, Streptococcus, Sutterella), and depletion within the first year of Bifidobacterium, Blautia, and butyrate producers (Roseburia, Faecalibacterium). Functional profiles often suggested delayed maturation and reduced short-chain fatty acid capacity. Evidence was limited by moderate risk of bias, residual confounding, and heterogeneous outcome definitions. These findings support distinct early-life microbial configurations associated with FA susceptibility versus tolerance, informing mechanism-based prevention. Trial Registration: PROSPERO CRD420251234739., The work was supported by a European grant (Physiological and Ecological impact of pre- and probiotic interventions in relation to food allergy in early-life, EcoBIOTIC), ERA-HDHL (2021: Food Hypersens—Addressing adverse and beneficial effects of food ingredients and food processing on hypersensitivities to food), Joint Action ‘European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)’—FOOD-HYPERSENS call and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spain (E.F.V. and M.C.C.). J.C. and M.L. were supported by EarlyFOOD (ANR-17-HDIM-0002) and EcoBIOTIC (ANR-20-CE15-0032) both JPI HDHL Era-Net. D.H. and H.O. were supported by the German Federal Ministry of Research, Technology and Space (BMFTR, previously BMBF; FKZ 01EA2207)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Maternal secretor status and human milk oligosaccharides influence the infant gut resistome

  • Samarra, Anna
  • Alcañiz, Alejandro J.
  • Quijada, Narciso M.
  • Renwick, Simone
  • George, Sergio
  • Sinha, Trishla
  • Martínez-Costa, Cecília
  • Segata, Nicola
  • Zhernakova, Alexandra
  • Bode, Lars
  • Collado, María Carmen
The infant gut resistome is established early in life and is shaped by perinatal exposures, yet the mechanisms underlying its modulation remain unclear. We combined shotgun metagenomics of fecal samples from 57 one-month-old infants and paired milk samples from 50 mothers in the MAMI cohort to investigate the influence of maternal secretor status on early-life resistome development. Longitudinal follow-up at 6 and 12 months, and also further validation in the independent Lifelines NEXT (LLNEXT) cohort, support our findings. Cesarean section (C-section) was associated with increased antibiotic resistance gene (ARG) diversity, whereas exclusive breastfeeding reduced ARG abundance and diversity. Maternal secretor status further modified resistome composition among exclusively breastfed infants. Human milk oligosaccharide profiling identified specific glycans underlying these associations, with 2'-fucosyllactose and 6'-sialyllactose showing negative correlations with distinct ARG classes. These findings identify human milk composition as a key determinant of early-life resistome assembly and a potential target for modulating antimicrobial resistance., A.S. acknowledges the Generalitat Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant. A.S. is the MOMI CORE Milk and Microbes postdoctoral Fellow, a program endowed by the Family Larsson-Rosenquist Foundation, Switzerland. L.B. is the UC San Diego Chair of Collaborative Human Milk Research, endowed in perpetuity by the Family Larsson-Rosenquist Foundation, Switzerland. A.J.A. acknowledges support by “Programa Investigo” and “Next Generation EU” funds. S.G. acknowledges the National Agency for Research & Development (ANID, Chile) for the postdoctoral fellowship grant (74230058). M.C.C. acknowledges the support from H2020-ERC Starting Grant (MAMI, ref. 639226), Horizon Europe Program (INITIALISE, ref. 101094099), Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)-FOOD-HYPERSENS call (ECOBIOTIC), and national funding through Programación Conjunta Internacional (PCI)- MICIN (ref. PCI2021-122059-2A), and also, Excellence Research Group-Generalitat Valenciana (GVA) Prometeo Program (NeoHealth ref. PROMETEO2020/12 & Microglocal ref. CIPROM2023/030). IATA-CSIC is a Center of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed